Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Hawkins

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 23, 2020
Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and EcumicinPaige M E Hawkins, Wendy Tran, Gayathri Nagalingam, et al.
The Journal of Infectious Diseases|January 1, 1992
Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected childrenF M Balis, P A Pizzo, K M Butler, et al.
ACS Infectious Diseases|October 23, 2025
ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent AntimycobacterialsPaige M E Hawkins, Max J Bedding, David M Hoi, et al.
Journal of the American Chemical Society|July 25, 2024
Expressed Protein Ligation in FlowLucas Kambanis, Anthony Ayoub, Max J Bedding, et al.
ACS Central Science|July 7, 2021
Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA DisplayAlexander Norman, Charlotte Franck, Mary Christie, et al.
Journal of Medicinal Chemistry|March 16, 2022
Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin APaige M E Hawkins, David M Hoi, Chen-Yi Cheung, et al.
ACS Chemical Biology|December 12, 2023
Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory ActivityMax J Bedding, Charlotte Franck, Jason Johansen-Leete, et al.
Nature Communications|January 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosisIsabel K Barter, Max J Bedding, Julia Leodolter, et al.
Cell|May 3, 2023
Clp-targeting BacPROTACs impair mycobacterial proteostasis and survivalDavid M Hoi, Sabryna Junker, Lukas Junk, et al.
Journal of Medicinal Chemistry|November 30, 2021
Synthetic Sansanmycin Analogues as Potent <i>Mycobacterium tuberculosis</i> Translocase I InhibitorsWendy Tran, Ali S Kusay, Paige M E Hawkins, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 23, 2020
Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and EcumicinPaige M E Hawkins, Wendy Tran, Gayathri Nagalingam, et al.
The Journal of Infectious Diseases|January 1, 1992
Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected childrenF M Balis, P A Pizzo, K M Butler, et al.
ACS Infectious Diseases|October 23, 2025
ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent AntimycobacterialsPaige M E Hawkins, Max J Bedding, David M Hoi, et al.
Journal of the American Chemical Society|July 25, 2024
Expressed Protein Ligation in FlowLucas Kambanis, Anthony Ayoub, Max J Bedding, et al.
ACS Central Science|July 7, 2021
Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA DisplayAlexander Norman, Charlotte Franck, Mary Christie, et al.
Journal of Medicinal Chemistry|March 16, 2022
Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin APaige M E Hawkins, David M Hoi, Chen-Yi Cheung, et al.
ACS Chemical Biology|December 12, 2023
Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory ActivityMax J Bedding, Charlotte Franck, Jason Johansen-Leete, et al.
Nature Communications|January 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosisIsabel K Barter, Max J Bedding, Julia Leodolter, et al.
Cell|May 3, 2023
Clp-targeting BacPROTACs impair mycobacterial proteostasis and survivalDavid M Hoi, Sabryna Junker, Lukas Junk, et al.
Journal of Medicinal Chemistry|November 30, 2021
Synthetic Sansanmycin Analogues as Potent <i>Mycobacterium tuberculosis</i> Translocase I InhibitorsWendy Tran, Ali S Kusay, Paige M E Hawkins, et al.
Pageof 3